Characterization and Targeting of Novel Activating BRAF Mutations in Pediatric Brain Tumors |
Children's Hospital of Philadelphia / Angela Waanders, MD, MPH |
Young Investigator Grants |
2010 |
Pennsylvania |
Characterization and Targeting of p53 Ubiquitination in Neuroblastoma.
|
Baylor College of Medicine / Eveline Barbieri, MD, PhD |
Young Investigator Grants |
2008 |
Texas |
Characterization of Chromatin Landscapes to Identify Therapeutic Vulnerabilities in Diffuse Midline Gliomas. |
Fred Hutchinson Cancer Research Center / Jay Sarthy, MD/PhD |
Young Investigator Grants |
2019 |
Washington |
Characterization of Novel OTX2-semaphorin Gene Signaling Pathways Regulating the ‘Grow and Go’ Arms of Highly Aggressive Medulloblastomas |
University of Manitoba / Tamra Werbowetski-Ogilvie, PhD |
Innovation Grants |
2017 |
Manitoba |
Characterization of Pre-Leukemia Associated with Familial RUNX1 Mutations |
Stanford University / Ravi Majeti, MD/PhD |
Familial RUNX1 Research Grants |
2016 |
California |
Characterization of the Role of Chromosome 1p Deletion in MYCN-Amplified Neuroblastoma |
University of California San Francisco / Miller Huang, PhD |
Young Investigator Grants |
2013 |
California |
Characterizing Inflammatory Phenotypes Associated with RUNX1 Deficiency |
Dana-Farber Cancer Institute / Waihay Wong, MD/PhD |
RUNX1 Early Career Investigator Grants |
2021 |
Massachusetts |
Characterizing Resistance Mechanisms to BET-Bromodomain Inhibition in MYC-amplified |
Broad Institute / Rameen Beroukhim, MD,PhD |
Innovation Grants |
2015 |
Massachusetts |
Characterizing the Developmental Context of Pediatric Leukemia
|
Icahn School of Medicine at Mount Sinai / Elvin Wagenblast, PhD |
'A' Award Grants |
2022 |
New York |
Chemical Genetics and CRISPRi/a Screen for Novel Therapeutic Targets in a Humanized Model for MYCN Associated High-Risk Pediatric Neuroblastoma |
University of California San Francisco / Zhenyi An, PhD |
Young Investigator Grants |
2015 |
California |